Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
INVA | Innoviva, Inc. | Officer | $653K | May 20, 2024 | ||
ETTX | Entasis Therapeutics Holdings Inc. | Chief of Pharma Sciences & MFG | Jul 7, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|